Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Drugs for Herpes Labialis (Oral Herpes) Market Research Report 2016

  • QYR681147
  • 119 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Production, means the output of Drugs for Herpes Labialis (Oral Herpes)

Revenue, means the sales value of Drugs for Herpes Labialis (Oral Herpes)

This report studies Drugs for Herpes Labialis in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

GSK

Novartis

Teva

Apotex

Cadila

Mylan

HETERO

Beech Tree

Onxeo

Foamix

Roxane

Livzon

Luoxin

Med shine

Haiwang

Kelun Group

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Drugs for Herpes Labialis in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Japan

Southeast Asia

India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Valacyclovir

Aciclovir

Famciclovir

Other

Split by application, this report focuses on consumption, market share and growth rate of Drugs for Herpes Labialis in each application, can be divided into

External use

Oral

Injection

Table of Contents

Global Drugs for Herpes Labialis Market Research Report 2016

1 Drugs for Herpes Labialis Market Overview

1.1 Product Overview and Scope of Drugs for Herpes Labialis (Oral Herpes)

1.2 Drugs for Herpes Labialis Segment by Type

1.2.1 Global Production Market Share of Drugs for Herpes Labialis by Type in 2015

1.2.2 Valacyclovir

1.2.3 Aciclovir

1.2.4 Famciclovir

1.2.5 Other

1.3 Drugs for Herpes Labialis Segment by Application

1.3.1 Drugs for Herpes Labialis Consumption Market Share by Application in 2015

1.3.2 External use

1.3.3 Oral

1.3.4 Injection

1.4 Drugs for Herpes Labialis Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Drugs for Herpes Labialis (2011-2021)

2 Global Drugs for Herpes Labialis Market Competition by Manufacturers

2.1 Global Drugs for Herpes Labialis Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 Global Drugs for Herpes Labialis Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Drugs for Herpes Labialis Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Drugs for Herpes Labialis Manufacturing Base Distribution, Sales Area and Product Type

2.5 Drugs for Herpes Labialis Market Competitive Situation and Trends

2.5.1 Drugs for Herpes Labialis Market Concentration Rate

2.5.2 Drugs for Herpes Labialis Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Drugs for Herpes Labialis Capacity, Production, Revenue (Value) by Region (2011-2016)

3.1 Global Drugs for Herpes Labialis Capacity and Market Share by Region (2011-2016)

3.2 Global Drugs for Herpes Labialis Production and Market Share by Region (2011-2016)

3.3 Global Drugs for Herpes Labialis Revenue (Value) and Market Share by Region (2011-2016)

3.4 Global Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.5 North America Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.6 Europe Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.7 China Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Japan Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.9 Southeast Asia Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

3.10 India Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Drugs for Herpes Labialis Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Drugs for Herpes Labialis Consumption by Regions (2011-2016)

4.2 North America Drugs for Herpes Labialis Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Drugs for Herpes Labialis Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Drugs for Herpes Labialis Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Drugs for Herpes Labialis Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Drugs for Herpes Labialis Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Drugs for Herpes Labialis Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Drugs for Herpes Labialis Production, Revenue (Value), Price Trend by Type

5.1 Global Drugs for Herpes Labialis Production and Market Share by Type (2011-2016)

5.2 Global Drugs for Herpes Labialis Revenue and Market Share by Type (2011-2016)

5.3 Global Drugs for Herpes Labialis Price by Type (2011-2016)

5.4 Global Drugs for Herpes Labialis Production Growth by Type (2011-2016)

6 Global Drugs for Herpes Labialis Market Analysis by Application

6.1 Global Drugs for Herpes Labialis Consumption and Market Share by Application (2011-2016)

6.2 Global Drugs for Herpes Labialis Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Drugs for Herpes Labialis Manufacturers Profiles/Analysis

7.1 GSK

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 GSK Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Novartis

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Novartis Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Teva

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Teva Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 Apotex

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 Apotex Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Cadila

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Cadila Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Mylan

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Mylan Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 HETERO

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 HETERO Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Beech Tree

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Beech Tree Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 Onxeo

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 Onxeo Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 Foamix

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 Drugs for Herpes Labialis Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 Foamix Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

7.11 Roxane

7.12 Livzon

7.13 Luoxin

7.14 Med shine

7.15 Haiwang

7.16 Kelun Group

8 Drugs for Herpes Labialis Manufacturing Cost Analysis

8.1 Drugs for Herpes Labialis Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Drugs for Herpes Labialis Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Drugs for Herpes Labialis Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Drugs for Herpes Labialis Market Forecast (2016-2021)

12.1 Global Drugs for Herpes Labialis Capacity, Production, Revenue Forecast (2016-2021)

12.2 Global Drugs for Herpes Labialis Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Drugs for Herpes Labialis Production Forecast by Type (2016-2021)

12.4 Global Drugs for Herpes Labialis Consumption Forecast by Application (2016-2021)

12.5 Drugs for Herpes Labialis Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List Of Tables and Figures

Figure Picture of Drugs for Herpes Labialis (Oral Herpes)

Figure Global Production Market Share of Drugs for Herpes Labialis by Type in 2015

Figure Product Picture of Valacyclovir

Table Major Manufacturers of Valacyclovir

Figure Product Picture of Aciclovir

Table Major Manufacturers of Aciclovir

Figure Product Picture of Famciclovir

Table Major Manufacturers of Famciclovir

Figure Product Picture of Other

Table Major Manufacturers of Other

Table Drugs for Herpes Labialis Consumption Market Share by Application in 2015

Figure External use Examples

Figure Oral Examples

Figure Injection Examples

Figure North America Drugs for Herpes Labialis Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Drugs for Herpes Labialis Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Drugs for Herpes Labialis Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Drugs for Herpes Labialis Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Drugs for Herpes Labialis Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Drugs for Herpes Labialis Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Drugs for Herpes Labialis Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Drugs for Herpes Labialis Capacity of Key Manufacturers (2015 and 2016)

Table Global Drugs for Herpes Labialis Capacity Market Share by Manufacturers (2015 and 2016)

Figure Global Drugs for Herpes Labialis Capacity of Key Manufacturers in 2015

Figure Global Drugs for Herpes Labialis Capacity of Key Manufacturers in 2016

Table Global Drugs for Herpes Labialis Production of Key Manufacturers (2015 and 2016)

Table Global Drugs for Herpes Labialis Production Share by Manufacturers (2015 and 2016)

Figure 2015 Drugs for Herpes Labialis Production Share by Manufacturers

Figure 2016 Drugs for Herpes Labialis Production Share by Manufacturers

Table Global Drugs for Herpes Labialis Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Drugs for Herpes Labialis Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Drugs for Herpes Labialis Revenue Share by Manufacturers

Table 2016 Global Drugs for Herpes Labialis Revenue Share by Manufacturers

Table Global Market Drugs for Herpes Labialis Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Drugs for Herpes Labialis Average Price of Key Manufacturers in 2015

Table Manufacturers Drugs for Herpes Labialis Manufacturing Base Distribution and Sales Area

Table Manufacturers Drugs for Herpes Labialis Product Type

Figure Drugs for Herpes Labialis Market Share of Top 3 Manufacturers

Figure Drugs for Herpes Labialis Market Share of Top 5 Manufacturers

Table Global Drugs for Herpes Labialis Capacity by Regions (2011-2016)

Figure Global Drugs for Herpes Labialis Capacity Market Share by Regions (2011-2016)

Figure Global Drugs for Herpes Labialis Capacity Market Share by Regions (2011-2016)

Figure 2015 Global Drugs for Herpes Labialis Capacity Market Share by Regions

Table Global Drugs for Herpes Labialis Production by Regions (2011-2016)

Figure Global Drugs for Herpes Labialis Production and Market Share by Regions (2011-2016)

Figure Global Drugs for Herpes Labialis Production Market Share by Regions (2011-2016)

Figure 2015 Global Drugs for Herpes Labialis Production Market Share by Regions

Table Global Drugs for Herpes Labialis Revenue by Regions (2011-2016)

Table Global Drugs for Herpes Labialis Revenue Market Share by Regions (2011-2016)

Table 2015 Global Drugs for Herpes Labialis Revenue Market Share by Regions

Table Global Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table China Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table India Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Drugs for Herpes Labialis Consumption Market by Regions (2011-2016)

Table Global Drugs for Herpes Labialis Consumption Market Share by Regions (2011-2016)

Figure Global Drugs for Herpes Labialis Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Drugs for Herpes Labialis Consumption Market Share by Regions

Table North America Drugs for Herpes Labialis Production, Consumption, Import & Export (2011-2016)

Table Europe Drugs for Herpes Labialis Production, Consumption, Import & Export (2011-2016)

Table China Drugs for Herpes Labialis Production, Consumption, Import & Export (2011-2016)

Table Japan Drugs for Herpes Labialis Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Drugs for Herpes Labialis Production, Consumption, Import & Export (2011-2016)

Table India Drugs for Herpes Labialis Production, Consumption, Import & Export (2011-2016)

Table Global Drugs for Herpes Labialis Production by Type (2011-2016)

Table Global Drugs for Herpes Labialis Production Share by Type (2011-2016)

Figure Production Market Share of Drugs for Herpes Labialis by Type (2011-2016)

Figure 2015 Production Market Share of Drugs for Herpes Labialis by Type

Table Global Drugs for Herpes Labialis Revenue by Type (2011-2016)

Table Global Drugs for Herpes Labialis Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Drugs for Herpes Labialis by Type (2011-2016)

Figure 2015 Revenue Market Share of Drugs for Herpes Labialis by Type

Table Global Drugs for Herpes Labialis Price by Type (2011-2016)

Figure Global Drugs for Herpes Labialis Production Growth by Type (2011-2016)

Table Global Drugs for Herpes Labialis Consumption by Application (2011-2016)

Table Global Drugs for Herpes Labialis Consumption Market Share by Application (2011-2016)

Figure Global Drugs for Herpes Labialis Consumption Market Share by Application in 2015

Table Global Drugs for Herpes Labialis Consumption Growth Rate by Application (2011-2016)

Figure Global Drugs for Herpes Labialis Consumption Growth Rate by Application (2011-2016)

Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GSK Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure GSK Drugs for Herpes Labialis Market Share (2011-2016)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Drugs for Herpes Labialis Market Share (2011-2016)

Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Teva Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Teva Drugs for Herpes Labialis Market Share (2011-2016)

Table Apotex Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Apotex Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Apotex Drugs for Herpes Labialis Market Share (2011-2016)

Table Cadila Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Cadila Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Cadila Drugs for Herpes Labialis Market Share (2011-2016)

Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Mylan Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Mylan Drugs for Herpes Labialis Market Share (2011-2016)

Table HETERO Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table HETERO Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure HETERO Drugs for Herpes Labialis Market Share (2011-2016)

Table Beech Tree Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Beech Tree Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Beech Tree Drugs for Herpes Labialis Market Share (2011-2016)

Table Onxeo Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Onxeo Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Onxeo Drugs for Herpes Labialis Market Share (2011-2016)

Table Foamix Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Foamix Drugs for Herpes Labialis Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Foamix Drugs for Herpes Labialis Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Drugs for Herpes Labialis (Oral Herpes)

Figure Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes)

Figure Drugs for Herpes Labialis Industrial Chain Analysis

Table Raw Materials Sources of Drugs for Herpes Labialis Major Manufacturers in 2015

Table Major Buyers of Drugs for Herpes Labialis (Oral Herpes)

Table Distributors/Traders List

Figure Global Drugs for Herpes Labialis Capacity, Production and Growth Rate Forecast (2016-2021)

Figure Global Drugs for Herpes Labialis Revenue and Growth Rate Forecast (2016-2021)

Table Global Drugs for Herpes Labialis Production Forecast by Regions (2016-2021)

Table Global Drugs for Herpes Labialis Consumption Forecast by Regions (2016-2021)

Table Global Drugs for Herpes Labialis Production Forecast by Type (2016-2021)

Table Global Drugs for Herpes Labialis Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390